Items where Author is "Farahani, N."
![]() | Up a level |
Article
(2025) Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies. Molecular Cancer. p. 51.
(2025) Long noncoding RNAs and HPV-related cervical cancer: Uncovering molecular mechanisms and clinical applications. Translational Oncology. p. 18. ISSN 1936-5233
(2024) Mechanistic insights into circRNA-mediated regulation of PI3K signaling pathway in glioma progression. Pathology Research and Practice. p. 11. ISSN 0344-0338
(2024) MicroRNA dysregulation and its impact on apoptosis-related signaling pathways in myelodysplastic syndrome. Pathology Research and Practice. p. 10. ISSN 0344-0338
(2024) Molecular Mechanisms and Therapeutic Potential of Resolvins in Cancer - Current Status and Perspectives. Current Medicinal Chemistry. pp. 5898-5917. ISSN 0929-8673
(2024) Unraveling the molecular landscape of osteoarthritis: A comprehensive review focused on the role of non-coding RNAs. Pathology Research and Practice. p. 24. ISSN 0344-0338
(2024) The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From molecular mechanism to future potential. Non-Coding Rna Research. pp. 1280-1291. ISSN 2468-2160
(2024) The function and mechanism of circRNAs in 5-fluorouracil resistance in tumors: Biological mechanisms and future potential. Pathology Research and Practice. p. 12. ISSN 0344-0338
(2024) The impact of exosomes on bone health: A focus on osteoporosis. Pathology Research and Practice. p. 19. ISSN 0344-0338
(2024) The importance of the circRNA/Wnt axis in gliomas: Biological functions and clinical opportunities. Pathology Research and Practice. p. 13. ISSN 0344-0338
(2024) The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways. Non-Coding Rna Research. pp. 1178-1189. ISSN 2468-2160
(2024) The role of curcumin in modulating circular RNAs and long non-coding RNAs in cancer. Clinical & Translational Oncology. p. 21. ISSN 1699-048X
(2022) Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update. Biochem Genet. pp. 453-481. ISSN 0006-2928
(2021) Autoantigen-specific immune tolerance in pathological and physiological cell death: Nanotechnology comes into view. International Immunopharmacology. ISSN 1567-5769
(2021) LncRNAs as putative biomarkers and therapeutic targets for Parkinson's disease. Neurol Sci. ISSN 1590-1874
(2016) Evaluation of MT1XT20 Single Quasi-Monomorphic Mononucleotide Marker for Characterizing Microsatellite Instability in Persian Lynch Syndrome Patients. Asian Pacific journal of cancer prevention : APJCP. pp. 4259-4265. ISSN 2476-762X (Electronic) 1513-7368 (Linking)
(2016) MT1XT20 single quasi-monomorphic mononucleotide marker for detection of microsatellite instability in iranian patients with hereditary nonpolyposis colorectal cancer (HNPCC). Journal of Isfahan Medical School. pp. 2120-2130. ISSN 10277595 (ISSN)
(2015) Methylation pattern of ALX4 gene promoter as a potential biomarker for blood-based early detection of colorectal cancer. Advanced biomedical research. p. 252. ISSN 2277-9175 (Print) 2277-9175 (Linking)